FuzionaireDX is a startup based in the United States.
FuzionaireDX develops scalable radiotheranostic programs using silicon-based HetSiFA® chemistry to create chemically matched diagnostic PET imaging and radioligand therapies for oncology treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.